NanoCarrier Co. Ltd

Research NanoCarrier Co. Ltd (3NQ) on Bullrun: market cap EUR 42.68M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker3NQ
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 42.68M
• Financial periodFY2025
• RevenueEUR 108.52M
• Revenue growth-19.9%
• Net income-EUR 835.38M
• Free cash flow-EUR 401.62M
• Gross margin72.0%

Valuation Snapshot

latest market cap is EUR 42.68M.

About NanoCarrier Co. Ltd

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd.

Frequently asked questions

What is NanoCarrier Co. Ltd's market cap?

NanoCarrier Co. Ltd's market capitalization is EUR 42.68M.

What does NanoCarrier Co. Ltd do?

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain;